litlas
Log inCreate account

P. Jeffrey Conn

Active 1984–2025

Also published as
P Jeffrey Conn
180
Papers
29,372
Citations
98
h-index
175
i10-index

Citations

Citations per year for P. Jeffrey Conn1966: 1 citations1985: 3 citations1986: 6 citations1987: 19 citations1988: 11 citations1989: 25 citations1990: 26 citations1991: 24 citations1992: 27 citations1993: 31 citations1994: 66 citations1995: 62 citations1996: 55 citations1997: 85 citations1998: 122 citations1999: 169 citations2000: 159 citations2001: 181 citations2002: 194 citations2003: 210 citations2004: 205 citations2005: 246 citations2006: 180 citations2007: 211 citations2008: 277 citations2009: 250 citations2010: 345 citations2011: 439 citations2012: 296 citations2013: 373 citations2014: 325 citations2015: 246 citations2016: 267 citations2017: 293 citations2018: 206 citations2019: 724 citations2020: 663 citations2021: 561 citations2022: 582 citations2023: 316 citations2024: 601 citations2025: 252 citations2026: 3 citations1967–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,589 citing papers, 35.7% of this breakdownUnited Kingdom: 523 citing papers, 7.2% of this breakdownChina: 412 citing papers, 5.7% of this breakdownItaly: 351 citing papers, 4.9% of this breakdownFrance: 343 citing papers, 4.7% of this breakdownGermany: 335 citing papers, 4.6% of this breakdownCanada: 280 citing papers, 3.9% of this breakdownJapan: 255 citing papers, 3.5% of this breakdownAustralia: 222 citing papers, 3.1% of this breakdownSwitzerland: 204 citing papers, 2.8% of this breakdownSpain: 187 citing papers, 2.6% of this breakdownIndia: 122 citing papers, 1.7% of this breakdown
0%35.7%Other 19.6%

Institutions

Fields

  • Neuroscience45.7%
  • Biochemistry, Genetics and Molecular Biology28.5%
  • Medicine16.7%
  • Computer Science2.5%
  • Psychology2.2%
  • Nursing1.2%
  • Other3.2%

Topics

  • Neuroscience and Neuropharmacology Research17.1%
  • Receptor Mechanisms and Signaling10.6%
  • Neurotransmitter Receptor Influence on Behavior4.1%
  • Ion channel regulation and function3%
  • Neuropeptides and Animal Physiology2.7%
  • Nicotinic Acetylcholine Receptors Study2.6%
  • Other59.9%

Coauthors

All papers

Open in search
  1. Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

    Authors: Colleen M. Niswender, P. Jeffrey Conn - The Annual Review of Pharmacology and Toxicology 2010 cited by 1,837

  2. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

    Authors: P. Jeffrey Conn, Arthur Christopoulos, Craig W. Lindsley - Nature Reviews Drug Discovery 2008 cited by 1,042

  3. Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia

    Authors: Shalini Dogra, P. Jeffrey Conn - Molecular Pharmacology 2022 cited by 73

  4. Metabotropic glutamate receptors: From the workbench to the bedside

    Authors: Ferdinando Nicoletti, Joël Bockaert, G.L. Collingridge, P. Jeffrey Conn, Francesco Ferraguti, D D Schoepp, Jarda T. Wroblewski, Jean‐Philippe Pin - Neuropharmacology 2010 cited by 637

  5. PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS

    Authors: P. Jeffrey Conn, Jean‐Philippe Pin - The Annual Review of Pharmacology and Toxicology 1997 cited by 3,074

  6. Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

    Authors: Huixian Wu, Chong Wang, Karen J. Gregory, Gye Won Han, Hyekyung P. Cho, Yan Xia, Colleen M. Niswender, Vsevolod Katritch, Jens Meiler, Vadim Cherezov, P. Jeffrey Conn, Raymond C. Stevens - Science 2014 cited by 550

  7. M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

    Authors: Weixing Shen, Joshua L. Plotkin, Veronica Francardo, Wai Kin D. Ko, Zhong Xie, Qin Li, Tim Fieblinger, Jürgen Wess, Richard R. Neubig, Craig W. Lindsley, P. Jeffrey Conn, Paul Greengard, Erwan Bézard, M. Angela Cenci, D. James Surmeier - Neuron 2015 cited by 249

  8. Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders

    Authors: Daniel J. Foster, P. Jeffrey Conn - Neuron 2017 cited by 238

  9. Targeting muscarinic receptors to treat schizophrenia

    Authors: Daniel J. Foster, Zoey Bryant, P. Jeffrey Conn - Behavioural Brain Research 2021 cited by 95

  10. Acute restraint stress redirects prefrontal cortex circuit function through mGlu5 receptor plasticity on somatostatin-expressing interneurons

    Authors: Max E. Joffe, James Maksymetz, Joseph R Luschinger, Shalini Dogra, Anthony S. Ferranti, Deborah J. Luessen, Isabel Gallinger, Zixiu Xiang, Hannah E. Branthwaite, Patrick R. Melugin, Kellie M. Williford, Samuel W. Centanni, Brenda C. Shields, Craig W. Lindsley, Erin S. Calipari, Cody A. Siciliano, Colleen M. Niswender, Michael R. Tadross, Danny G. Winder, P. Jeffrey Conn - Neuron 2022 cited by 72

  11. Antipsychotic-like Effects of M 4 Positive Allosteric Modulators Are Mediated by CB 2 Receptor-Dependent Inhibition of Dopamine Release

    Authors: Daniel J. Foster, Jermaine M. Wilson, Daniel H. Remke, M. Suhaib Mahmood, M. Jashim Uddin, Jürgen Wess, Sachin Patel, Lawrence J. Marnett, Colleen M. Niswender, Carrie K. Jones, Zixiu Xiang, Craig W. Lindsley, Jerri M. Rook, P. Jeffrey Conn - Neuron 2016 cited by 152

  12. Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders

    Authors: Mark S. Moehle, P. Jeffrey Conn - Movement Disorders 2019 cited by 69

  13. Selective Activation of M4Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents

    Authors: Michael Bubser, Thomas M. Bridges, Ditte Dencker, Robert W. Gould, Michael Grannan, Meredith J. Noetzel, Atin Lamsal, Colleen M. Niswender, J. Scott Daniels, Michael S. Poslusney, Bruce J. Melancon, James C. Tarr, Frank W. Byers, Jürgen Wess, Mark E. Duggan, John Dunlop, Michael W. Wood, Nicholas J. Brandon, Michael R. Wood, Craig W. Lindsley, P. Jeffrey Conn, Carrie K. Jones - ACS Chemical Neuroscience 2014 cited by 155

  14. N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl- d -aspartate receptor activity

    Authors: Cyrille Sur, Pierre Mallorga, Marion Wittmann, Marlene A. Jacobson, Danette Pascarella, Jacinta B. Williams, Philip E. Brandish, Douglas J. Pettibone, Edward M. Scolnick, P. Jeffrey Conn - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 291

  15. Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders

    Authors: Sean P. Moran, James Maksymetz, P. Jeffrey Conn - Trends in Pharmacological Sciences 2019 cited by 132

  16. D1 and D2 medium spiny neurons in the nucleus accumbens core have distinct and valence-independent roles in learning

    Authors: Jennifer E. Zachry, Munir Gunes Kutlu, Hye Jean Yoon, Michael Z. Leonard, Maxime Chevée, Dev Patel, Anthony Gaidici, Veronika Kondev, Kimberly C. Thibeault, Rishik Bethi, Jennifer Tat, Patrick R. Melugin, Atagun U. Isiktas, Max E. Joffe, Denise J. Cai, P. Jeffrey Conn, Brad A. Grueter, Erin S. Calipari - Neuron 2023 cited by 75

  17. Activation of the genetically defined m1 muscarinic receptor potentiates N -methyl- d -aspartate (NMDA) receptor currents in hippocampal pyramidal cells

    Authors: Michael J. Marino, Susan T. Rouse, Allan I. Levey, Lincoln T. Potter, P. Jeffrey Conn - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 274

  18. A Selective Allosteric Potentiator of the M1Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning

    Authors: Jana K. Shirey, Ashley E. Brady, Paulianda J. Jones, Albert A. Davis, Thomas M. Bridges, J. Phillip Kennedy, Satyawan Jadhav, Usha N. Menon, Zixiu Xiang, Mona L. Watson, Edward P. Christian, James Doherty, Michael C. Quirk, Dean H. Snyder, James J. Lah, Allan I. Levey, Michelle M. Nicolle, Craig W. Lindsley, P. Jeffrey Conn - Journal of Neuroscience 2009 cited by 238

  19. Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders

    Authors: Shalini Dogra, P. Jeffrey Conn - Neuropharmacology 2021 cited by 72

  20. Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease

    Authors: Deborah J. Luessen, P. Jeffrey Conn - Pharmacological Reviews 2022 cited by 34

  21. Metabotropic Glutamate Receptors 1 and 5 Differentially Regulate CA1 Pyramidal Cell Function

    Authors: Guido Mannaioni, Michael J. Marino, Ornella Valenti, Stephen F. Traynelis, P. Jeffrey Conn - Journal of Neuroscience 2001 cited by 441

  22. Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders

    Authors: P. Jeffrey Conn, Carrie K. Jones, Craig W. Lindsley - Trends in Pharmacological Sciences 2009 cited by 285

  23. Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders

    Authors: P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, Colleen M. Niswender - Nature Reviews Drug Discovery 2014 cited by 260

  24. Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

    Authors: Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn - Chemical Reviews 2016 cited by 179